chemical factors might further promote hematopoiesis [21]. In the
following section, we describe a protocol for using the random
positioning machine (RPM) bioreactor to culture hPSCs and the
large-scale production of HSPCs in a chemically defined system. We
identify the characteristics of the cells and analyze the efficiency of
hematopoietic differentiation in the RPM bioreactor by immuno-
histochemistry and flow cytometry.
2
Materials
2.1
Cell Lines
Human ESC line H1 is obtained from Wicell Research Institute,
Inc., Madison, WI.
2.2
Cell Culture
Medium and Reagents
1. Medium
for
undifferentiated
human
ESCs
expansion:
TeSR™-E8™medium (Cat# 05990, STEMCELL Technolo-
gies), basal medium store at 4 C, 25 supplement store at
20 C.
2. Matrigel for undifferentiated human ESCs expansion: Matrigel
Matrix HESC-qualified (BioCoat, 354277); Matrigel for
human ESCs differentiation: Corning Matrigel Growth Factor
Reduced
Basement
Membrane
Matrix
(Corning,
Cat#354230). The final dilution of Matrigel should be 1:50.
3. IF9S basal medium for human ESC differentiation: The for-
mulation of IF9S is list in Table 1 according to previously
described [22]. Store at 4 C.
4. Mesoderm induction medium: IF9S basal medium with
50 ng/mL BMP4 (PeproTech), 15 ng/mL ACTIVIN A
(PeproTech) and 1.5 μM CHIR99021 (STEMCELL™Tech-
nologies) . Stable for 1 week at 4 C.
5. Hemogenic
endothelium
progenitor
cell
differentiation
medium: IF9S basal medium with 10 μM SB431542 (R&D
Systems), 50 ng/mL VEGF (R&D Systems), 50 ng/mL bFGF
(PeproTech), and 50 ng/mL SCF (R&D Systems). Stable for
1 week at 4 C.
6. Hematopoietic progenitor cells medium: IF9S basal medium
with 50 ng/mL VEGF (R&D Systems), 50 ng/mL bFGF
(PeproTech), 50 ng/mL SCF (R&D Systems), 10 ng/mL
IL-3 (R&D Systems), 50 ng/mL IL-6 (R&D Systems), and
20 ng/mL TPO (Sino Biological). Stable for 1 week at 4 C.
2.3
Bioreactor
Equipment
The random positioning machine (SM-31J) for cell culture is
designed by the National Center of Space Science, Chinese Acad-
emy of Sciences, which is a microgravity simulated device. The
device included two parts: (1) biaxial drive rotator, which can
support 3D rotation of cell culture vessel (Fig. 1a), and (2) the
electronic control system, aims to supply power and to adjust the
rotation speed of rotator (Fig. 1b).
Hematopoietic Stem/Progenitor Cell Differentiation in Random Positioning. . .
57